The class of chemicals known as ERGIC-2 activators predominantly influences the intricate processes of protein transport between the endoplasmic reticulum (ER) and Golgi apparatus. Given ERGIC-2's involvement in these processes, compounds that alter the dynamics of protein folding, vesicle formation, or intracellular calcium levels inherently affect the functional state of ERGIC-2. The ER-Golgi transport system is incredibly sensitive to alterations in intracellular calcium levels. Compounds like A23187 and Thapsigargin, which modulate calcium concentrations, play a pivotal role in vesicle fusion and protein transport. ERGIC-2's function is indirectly influenced by such alterations, emphasizing its integral role in maintaining cellular homeostasis during these protein transport processes.
Additionally, GTPases such as Sar1p are crucial for initiating COPII vesicle formation, a critical step in ER-Golgi transport. Activation of these GTPases or the introduction of non-hydrolyzable GTP analogs like Guanosine 5'-O-(3-thiotriphosphate) showcases the importance of nucleotide-dependent processes in the larger transport system in which ERGIC-2 operates.
Furthermore, the introduction of chemicals like Brefeldin A can disrupt the transport system. However, the subsequent recovery or adaptation of the cell to such disruptions indirectly highlights ERGIC-2's robustness and adaptability. It's a testament to the protein's pivotal role in ensuring proper protein transport and secretion. Compounds such as Forskolin, which can elevate cAMP levels, underscore the importance of secondary messenger systems in regulating protein secretion pathways. As cAMP levels rise, the secretory pathway, including the processes ERGIC-2 is involved in, can be enhanced. Similarly, compounds affecting glycosylation or inhibiting specific Golgi functions (like Golgicide A) underline the tight interplay of cellular processes and how they intersect with ERGIC-2's function. As the cell encounters these chemical modulations, ERGIC-2 stands as a central component in the cell's response, ensuring that protein transport remains as efficient and effective as possible.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Nigericin sodium salt | 28643-80-3 | sc-201518A sc-201518 sc-201518B sc-201518C sc-201518D | 1 mg 5 mg 25 mg 1 g 5 g | $46.00 $112.00 $240.00 $7079.00 $27417.00 | 9 | |
Potassium ionophore, disrupting trans-Golgi pH gradient and thus affecting protein transport. The disruption may indirectly influence ERGIC-2's function in the reestablishment of normal transport. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, elevating cAMP levels. Elevated cAMP can promote protein secretion and may indirectly modulate ERGIC-2 activity related to protein transport. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
ER calcium ATPase inhibitor, leading to decreased calcium levels in the ER and impacting protein folding and transport. The stress induced can indirectly affect ERGIC-2's role in the ER-Golgi transport system. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophore disrupting intracellular calcium levels, which are crucial for vesicle fusion and protein transport. The alterations in calcium dynamics can indirectly influence ERGIC-2 activity. | ||||||
Guanosine 5′-O-(3-thiotriphosphate) tetralithium salt | 94825-44-2 | sc-202639 | 10 mg | $465.00 | ||
A non-hydrolyzable GTP analog that can activate GTPases involved in vesicle formation. This can impact vesicular transport systems in which ERGIC-2 is involved. | ||||||
SecinH3 | 853625-60-2 | sc-203260 | 5 mg | $278.00 | 6 | |
Inhibitor of cytohesins, affecting ARF protein activation and subsequently vesicle transport. It can influence the broader transport pathway in which ERGIC-2 operates. | ||||||